Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites

Table 2 Clinical efficacy of laparoscope-assisted CHIPC in patients with gastric cancer complicated by malignant ascites

Case No.	Therapeutic outcome	Port-site seeding (+/-)	KPS mark		Survival time (mo)	Death/living
			Before treatment	After treatment
1	CR	-	40	80	9	Death
2	CR	-	60	90	7	Death
3	CR	-	60	70	5	Death
4	CR	-	50	80	5	Death
5	CR	-	70	90	7	Death
6	CR	-	50	70	4	Death
7	PR	+	40	60	2	Death
8	CR	-	50	70	4	Death
9	CR	-	50	90	5	Death
10	CR	-	60	80	5	Death
11	CR	-	60	80	4	Death
12	PR	+	50	70	3	Death
13	CR	-	40	80	7	Death
14	CR	-	70	80	7	Living
15	CR	-	60	70	4	Living
16	CR	-	60	80	6	Living

KPS: Karnofsky; CR: Complete remission; PR: Partial remission.